We’re just a month away from our next big biotech event in Boston, New England’s Emerging Biotech Stars. We have a stellar lineup planned for this afternoon event, which will be held April 4 at Biogen Idec in Cambridge, MA.
Today we’re rolling out the official agenda for this exciting half-day conference. We’ll hear from the CEOs of five of the area’s most dynamic biotech startups: Genocea’s Chip Clark, Dicerna’s Doug Fambrough, Adimab’s Tillman Gerngross, Syndax’s Joanna Horobin, and Aileron’s Joseph Yanchik. We’ll have keynote addresses from George Scangos, CEO of Biogen Idec, and Mark Levin, a partner at Third Rock Ventures.
And Doug Williams, executive vice president for R&D at Biogen, will draw on his experience overhauling his company’s pipeline when he talks to the crowd about reinvigorating research.
The afternoon will also include a panel on one of the hottest topics in biotech: obtaining research grants from foundations. We’ll hear tips from Julia Greenstein of the Juvenile Diabetes Research Foundation and Dana Callow, managing general partner of Boston Millennia Partners. Louise Perkins from Multiple Myeloma Research Foundation will be there, along with Michael Kauffman, CEO of Karyopharm, which received $1 million in funding from that foundation last year. The panel will be moderated by Jens Eckstein, president of SR One.
New England’s Emerging Biotech Stars will run from 1:30 to 6:30 p.m. at Biogen Idec Building 8, 15 Cambridge Center in Cambridge. There will be plenty of time for networking during this afternoon with the area’s biotech leaders and rising stars. Get your tickets today, and check out our special discounted prices for students and startups. We look forward to seeing you at Biogen on April 4.
